BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.90M | 6.14M | 10.08M | 10.47M | 10.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.90M | 6.14M | 10.08M | 10.47M | 10.96M |
| Cost of Revenue | 3.06M | 2.38M | 299.70K | 1.20M | 685.20K |
| Gross Profit | 4.84M | 3.76M | 9.78M | 9.27M | 10.28M |
| SG&A Expenses | 11.82M | 10.97M | 15.75M | 5.80M | 8.15M |
| Depreciation & Amortization | 689.30K | 540.40K | 47.10K | 57.60K | 60.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.30M | 15.02M | 17.58M | 9.02M | 10.85M |
| Operating Income | -8.40M | -8.88M | -7.50M | 1.45M | 112.80K |
| Income Before Tax | -8.97M | -8.82M | -7.32M | 1.47M | 178.00K |
| Income Tax Expenses | -- | -- | 3.94M | 707.70K | 167.30K |
| Earnings from Continuing Operations | -8.97M | -8.82M | -11.26M | 761.10K | 10.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.97M | -8.82M | -11.26M | 761.10K | 10.60K |
| EBIT | -8.40M | -8.88M | -7.50M | 1.45M | 112.80K |
| EBITDA | -7.71M | -8.34M | -7.45M | 1.51M | 173.50K |
| EPS Basic | -0.52 | -0.52 | -0.68 | 0.05 | 0.00 |
| Normalized Basic EPS | -0.30 | -0.33 | -0.28 | 0.05 | 0.01 |
| EPS Diluted | -0.52 | -0.52 | -0.68 | 0.03 | 0.00 |
| Normalized Diluted EPS | -0.30 | -0.33 | -0.28 | 0.04 | 0.00 |
| Average Basic Shares Outstanding | 17.33M | 16.85M | 16.60M | 16.75M | 16.71M |
| Average Diluted Shares Outstanding | 17.33M | 16.85M | 16.60M | 23.24M | 23.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |